Personalized emergency medical monitoring and transmission system
First Claim
1. An emergency medical monitoring and transmission system capable of sending a message to both a personal caretaker and an emergency response center, said system comprising:
- a wearable monitor/transmitter device that includes a glucose level detector to detect a blood glucose level of a patient, a geolocation system that indicates location of said patient, and a communication interface to send a message;
a processor unit operable with said wearable monitor/transmitter device that collects information produced by said glucose level detector and said geolocation system to determine whereabouts and existence of a hypoglycemic or hyperglycemic condition of said patient, wherein said processor unit effects collection of blood glucose levels at time instances that vary according to proximity of a detected level to an unsafe limit;
said processor unit further including program instructions to effect assembly of said message that includes patient identifier data, whereabouts of said patient, and an emergency alert indication; and
said processor being further operable to effect activation of said communication interface to transmit said message in response to a hypoglycemic or hyperglycemic condition of said patient;
a transmission path of said communication interface to send, in response to said emergency alert indication, an emergency message to an emergency response center and to said personal caretaker to simultaneously indicate at at least two locations that the patient requires assistance; and
a caretaker receiver accessible by a personal caretaker of said patient to receive said message and to produce an alarm indicating that the patient requires assistance in response to receipt of said emergency alert indication.
0 Assignments
0 Petitions

Accused Products

Abstract
A portable emergency medical monitoring and transmission system capable of sending a message to a personal caretaker and/or an emergency response center. The system includes a wearable monitor/transmitter device including a glucose level detector, a geolocation system, and a communication interface to send and/or receive a message. A processor operable within the device collects information produced by the glucose level detector and the geolocation system to determine whereabouts and existence of a hypoglycemic or hyperglycemic condition of the patient. Upon detecting an unsafe medication condition, the processor assembles a message that includes patient identifier data, whereabouts of said patient, and an emergency alert indication; and activates a transmitter to transmit an emergency message in response to a hypoglycemic or hyperglycemic condition. An optional caretaker receiver receives the message and produces a local alarm indicating that the patient requires assistance. A transmission path of the transmitter conveys, in response to an emergency alert indication, the emergency message to an emergency response center indicating that the patient needs help.
227 Citations
Analyte monitoring device and methods of use | ||
Patent #
US 7,885,699 B2
Filed 08/06/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 7,869,853 B1
Filed 08/06/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Dynamic user interface for the temporarily impaired based on automatic analysis for speech patterns | ||
Patent #
US 7,962,342 B1
Filed 08/22/2006
|
Current Assignee
Avaya Incorporated
|
Original Assignee
Avaya Incorporated
|
Sensory Enhancement Systems and Methods in Personal Electronic Devices | ||
Patent #
US 20110121965A1
Filed 01/13/2011
|
Current Assignee
Innovation Specialists LLC
|
Original Assignee
Innovation Specialists LLC
|
Analyte monitoring system and method | ||
Patent #
US 7,920,907 B2
Filed 06/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 7,928,850 B2
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
HYPOGLYCEMIC TREATMENT METHODS AND SYSTEMS | ||
Patent #
US 20110118578A1
Filed 11/17/2009
|
Current Assignee
Roche Diabetes Care Inc.
|
Original Assignee
Roche Diagnostics Operations Incorporated
|
Detection of extreme hypoglycemia or hyperglycemia based on automatic analysis of speech patterns | ||
Patent #
US 7,925,508 B1
Filed 08/22/2006
|
Current Assignee
Avaya Incorporated
|
Original Assignee
Avaya Incorporated
|
Blood glucose tracking apparatus | ||
Patent #
US 7,976,778 B2
Filed 06/22/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Smartphone emergency alarm | ||
Patent #
US 20110230161A1
Filed 03/22/2011
|
Current Assignee
Fredric Mark Newman
|
Original Assignee
Fredric Mark Newman
|
System, device and process for remotely controlling a medical device | ||
Patent #
US 8,015,972 B2
Filed 12/30/2006
|
Current Assignee
Genadyne Biotechnologies Inc.
|
Original Assignee
Shahzad Pirzada
|
Glucose measuring device for use in personal area network | ||
Patent #
US 8,066,639 B2
Filed 06/04/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Glucose measuring device integrated into a holster for a personal area network device | ||
Patent #
US 8,029,443 B2
Filed 09/26/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Cooling off period prior to sending dependent on user's state | ||
Patent #
US 8,041,344 B1
Filed 06/26/2007
|
Current Assignee
Avaya Incorporated
|
Original Assignee
Avaya Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 7,860,544 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing an alert utilizing geographic locations | ||
Patent #
US 7,787,857 B2
Filed 06/12/2006
|
Current Assignee
Garmin Limited
|
Original Assignee
Garmin Limited
|
AUTOMATED ANALYSIS OF DATA COLLECTED BY IN-VIVO DEVICES | ||
Patent #
US 20100179820A1
Filed 01/09/2009
|
Current Assignee
Cerner Innovation Inc.
|
Original Assignee
Cerner Innovation Inc.
|
METHODS AND SYSTEMS FOR PROMOTING GLUCOSE MANAGEMENT | ||
Patent #
US 20100261987A1
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 7,811,231 B2
Filed 12/26/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing basal profile modification in analyte monitoring and management systems | ||
Patent #
US 7,766,829 B2
Filed 11/04/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
GLUCOSE METER ADAPTABLE FOR USE WITH HANDHELD DEVICES, AND ASSOCIATED COMMUNICATION NETWORK | ||
Patent #
US 20100279418A1
Filed 05/04/2010
|
Current Assignee
Spencer Johnson, Loren Robert Larson
|
Original Assignee
Spencer Johnson, Loren Robert Larson
|
EMERGENCY NOTIFICATION SYSTEM | ||
Patent #
US 20090100509A1
Filed 08/14/2008
|
Current Assignee
Wendy Wolfsberger
|
Original Assignee
Wendy Wolfsberger
|
Wearable Automated Blood Sampling and Monitoring System | ||
Patent #
US 20090264720A1
Filed 04/17/2008
|
Current Assignee
IntelliDx Inc.
|
Original Assignee
Cooper Health System
|
Method and system for powering an electronic device | ||
Patent #
US 7,620,438 B2
Filed 03/31/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Medical emergency alert system and method | ||
Patent #
US 20090322513A1
Filed 06/11/2009
|
Current Assignee
Ching Ching Huang, Franklin Dun-Jen Hwang
|
Original Assignee
Ching Ching Huang, Franklin Dun-Jen Hwang
|
System and method for adaptively adjusting patient data collection in an automated patient management environment | ||
Patent #
US 20080021287A1
Filed 06/26/2006
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
SYSTEMS AND METHODS FOR DETECTING HYPOGLYCEMIC EVENTS HAVING A REDUCED INCIDENCE OF FALSE ALARMS | ||
Patent #
US 20080208026A1
Filed 10/30/2007
|
Current Assignee
LifeScan IP Holdings LLC
|
Original Assignee
Lifescan Incorporated
|
Automatic parameter status on an implantable medical device system | ||
Patent #
US 20070060797A1
Filed 08/31/2005
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
PROCESS AND SYSTEM FOR SETTING A PATIENT MONITOR | ||
Patent #
US 20070232867A1
Filed 12/19/2006
|
Current Assignee
Dragerwerk AG Company KGaA
|
Original Assignee
Draeger Medical Incorporated
|
Method and apparatus for providing rolling data in communication systems | ||
Patent #
US 8,123,686 B2
Filed 03/01/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
METHOD AND APPARATUS FOR PROVIDING AN ALERT UTILIZING GEOGRAPHIC LOCATIONS | ||
Patent #
US 20070288157A1
Filed 06/12/2006
|
Current Assignee
Garmin Limited
|
Original Assignee
Garmin Limited
|
Method and device for early signal attenuation detection using blood glucose measurements | ||
Patent #
US 8,103,456 B2
Filed 01/29/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing leak detection in data monitoring and management systems | ||
Patent #
US 8,112,240 B2
Filed 04/29/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 8,149,117 B2
Filed 08/29/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,162,829 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
METHOD AND SYSTEM FOR DETERMINING WHEN TO REPOSITION A PHYSIOLOGICAL SENSOR | ||
Patent #
US 20120108912A1
Filed 12/12/2011
|
Current Assignee
Covidien LP
|
Original Assignee
Nellcor Puritan Bennett LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,175,673 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,177,716 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 8,187,183 B2
Filed 10/11/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sensory Enhancement Systems and Methods in Personal Electronic Devices | ||
Patent #
US 20120139721A1
Filed 02/13/2012
|
Current Assignee
Innovation Specialists LLC
|
Original Assignee
Innovation Specialists LLC
|
Sensory Enhancement Systems and Methods in Personal Electronic Devices | ||
Patent #
US 20120154144A1
Filed 03/01/2012
|
Current Assignee
Innovation Specialists LLC
|
Original Assignee
Innovation Specialists LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,224,413 B2
Filed 10/10/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,558 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,557 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,555 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 8,226,891 B2
Filed 03/31/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,231,532 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 8,236,242 B2
Filed 02/12/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,235,896 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,255,031 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,260,392 B2
Filed 06/09/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,265,726 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 8,268,243 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,273,022 B2
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,275,439 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,287,454 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Cocking and advancing mechanism for analyte testing device | ||
Patent #
US 8,292,826 B1
Filed 11/30/2011
|
Current Assignee
Yofimeter LLC
|
Original Assignee
Yofimeter LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,306,598 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Test unit cartridge for analyte testing device | ||
Patent #
US 8,333,717 B1
Filed 11/30/2011
|
Current Assignee
Yofimeter LLC
|
Original Assignee
Yofimeter LLC
|
Methods for using an analyte testing device | ||
Patent #
US 8,333,716 B1
Filed 07/20/2011
|
Current Assignee
Yofimeter LLC
|
Original Assignee
Yofimeter LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,336 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,337 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,353,829 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,357,091 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 8,362,904 B2
Filed 04/18/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,366,614 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,372,005 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,380,273 B2
Filed 04/11/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sensory enhancement systems and methods in personal electronic devices | ||
Patent #
US 8,390,445 B2
Filed 03/01/2012
|
Current Assignee
Innovation Specialists LLC
|
Original Assignee
Innovation Specialists LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,391,945 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,409,131 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for detecting hypoglycemic events having a reduced incidence of false alarms | ||
Patent #
US 8,439,837 B2
Filed 10/30/2007
|
Current Assignee
LifeScan IP Holdings LLC
|
Original Assignee
Lifescan Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 8,456,301 B2
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Glucose measuring module and insulin pump combination | ||
Patent #
US 8,460,243 B2
Filed 06/10/2003
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Abbott Diabetes Care Incorporated, Deltek Inc.
|
Analyte monitoring system and methods | ||
Patent #
US 8,461,985 B2
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,465,425 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for early signal attenuation detection using blood glucose measurements | ||
Patent #
US 8,473,220 B2
Filed 01/23/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,473,021 B2
Filed 07/31/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Emergency Medical Diagnosis and Communications Device | ||
Patent #
US 20130172689A1
Filed 07/25/2012
|
Current Assignee
Clifford H. Kraft, Vasilios D. Dossas, Lady C. Dy
|
Original Assignee
Clifford H. Kraft, Vasilios D. Dossas, Lady C. Dy
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,480,580 B2
Filed 04/19/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Glucose measuring device for use in personal area network | ||
Patent #
US 8,512,239 B2
Filed 04/20/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing basal profile modification in analyte monitoring and management systems | ||
Patent #
US 8,585,591 B2
Filed 07/10/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 8,593,287 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for powering an electronic device | ||
Patent #
US 8,593,109 B2
Filed 11/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,597,189 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 8,597,575 B2
Filed 07/23/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,612,159 B2
Filed 02/16/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,617,071 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 8,622,903 B2
Filed 05/25/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,622,906 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,641,619 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Glucose measuring device for use in personal area network | ||
Patent #
US 8,647,269 B2
Filed 04/20/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,649,841 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,652,043 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,660,627 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for determining elapsed sensor life | ||
Patent #
US 8,665,091 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,666,469 B2
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,668,645 B2
Filed 01/03/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,670,815 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,672,844 B2
Filed 02/27/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for early signal attenuation detection using blood glucose measurements | ||
Patent #
US 8,676,513 B2
Filed 06/21/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,688,188 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Automated analysis of data collected by in-vivo devices | ||
Patent #
US 8,688,467 B2
Filed 01/09/2009
|
Current Assignee
Cerner Innovation Inc.
|
Original Assignee
Cerner Innovation Inc.
|
Method and system for determining when to reposition a physiological sensor | ||
Patent #
US 8,690,770 B2
Filed 12/12/2011
|
Current Assignee
Covidien LP
|
Original Assignee
Covidien LP
|
COMMUNICATION PROTOCOL IMPROVEMENT TO RECOVER DATA FROM A CONTINUOUS GLUCOSE MONITOR | ||
Patent #
US 20140107449A1
Filed 10/12/2012
|
Current Assignee
Roche Diabetes Care Inc.
|
Original Assignee
Roche Diagnostics Operations Incorporated
|
Method and system for providing contextual based medication dosage determination | ||
Patent #
US 8,732,188 B2
Filed 02/15/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,348 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,346 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,738,109 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,744,545 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Blood glucose tracking apparatus | ||
Patent #
US 8,765,059 B2
Filed 10/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing data communication in continuous glucose monitoring and management system | ||
Patent #
US 8,771,183 B2
Filed 02/16/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,774,887 B2
Filed 03/24/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
MANAGING EDUCATIONAL CONTENT BASED ON DETECTED STRESS STATE | ||
Patent #
US 20140222732A1
Filed 12/18/2013
|
Current Assignee
JB IP Acquisitions LLC
|
Original Assignee
BodyMedia Incorporated
|
MANAGING EDUCATIONAL CONTENT BASED ON DETECTED STRESS STATE AND AN INDIVIDUALS PREDICTED TYPE | ||
Patent #
US 20140220525A1
Filed 12/18/2013
|
Current Assignee
JB IP Acquisitions LLC
|
Original Assignee
BodyMedia Incorporated
|
Automatic parameter status on an implantable medical device system | ||
Patent #
US 8,827,904 B2
Filed 08/31/2005
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,840,553 B2
Filed 02/26/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Emergency Medical Diagnosis and Communications Device | ||
Patent #
US 20140316285A1
Filed 01/30/2014
|
Current Assignee
Clifford H. Kraft, Vasilios D. Dossas, Lady C. Dy
|
Original Assignee
Clifford H. Kraft, Vasilios D. Dossas, Lady C. Dy
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,880,137 B2
Filed 04/18/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and method for non-intrusive health monitoring in the home | ||
Patent #
US 8,905,927 B2
Filed 11/30/2010
|
Current Assignee
Universal Electronics Inc.
|
Original Assignee
Universal Electronics Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,915,850 B2
Filed 03/28/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,920,319 B2
Filed 12/28/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Multi-function analyte test device and methods therefor | ||
Patent #
US 8,930,203 B2
Filed 02/03/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for powering an electronic device | ||
Patent #
US 8,933,664 B2
Filed 11/25/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte testing devices | ||
Patent #
US 8,961,432 B2
Filed 04/23/2013
|
Current Assignee
Yofimeter LLC
|
Original Assignee
Yofimeter LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,974,386 B2
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods for managing power and noise | ||
Patent #
US 8,993,331 B2
Filed 08/31/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 9,000,929 B2
Filed 11/22/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,332 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,331 B2
Filed 12/29/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,014,773 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 9,035,767 B2
Filed 05/30/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 9,039,975 B2
Filed 12/02/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,042,953 B2
Filed 03/02/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Device and System for Locating and Operating a Medical Device | ||
Patent #
US 20150151051A1
Filed 12/03/2014
|
Current Assignee
Micrel Medical Devices S.A.
|
Original Assignee
Micrel Medical Devices S.A.
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,695 B2
Filed 04/12/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,697 B2
Filed 10/27/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for early signal attenuation detection using blood glucose measurements | ||
Patent #
US 9,066,709 B2
Filed 03/17/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,694 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,072,477 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,078,607 B2
Filed 06/17/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing rolling data in communication systems | ||
Patent #
US 9,095,290 B2
Filed 02/27/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 9,177,456 B2
Filed 06/10/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Communication protocol improvement to recover data from a continuous glucose monitor | ||
Patent #
US 9,226,702 B2
Filed 10/12/2012
|
Current Assignee
Roche Diabetes Care Inc.
|
Original Assignee
Roche Diabetes Care Inc.
|
Error detection in critical repeating data in a wireless sensor system | ||
Patent #
US 9,226,701 B2
Filed 04/28/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System, device and process for remotely controlling a medical device | ||
Patent #
US 9,278,183 B2
Filed 08/08/2011
|
Current Assignee
Genadyne Biotechnologies Inc.
|
Original Assignee
Shahzad Pirzada
|
Analyte monitoring system and methods | ||
Patent #
US 9,314,198 B2
Filed 04/03/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte signal processing device and methods | ||
Patent #
US 9,314,195 B2
Filed 08/31/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing notification function in analyte monitoring systems | ||
Patent #
US 9,320,461 B2
Filed 09/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing basal profile modification in analyte monitoring and management systems | ||
Patent #
US 9,323,898 B2
Filed 11/15/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,716 B2
Filed 12/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,714 B2
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for powering an electronic device | ||
Patent #
US 9,380,971 B2
Filed 12/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and systems for promoting glucose management | ||
Patent #
US 9,446,194 B2
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 9,477,811 B2
Filed 06/23/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,498,159 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
METHOD AND APPARATUS FOR MONITORING A FUNCTIONAL CAPACITY OF AN INDIVIDUAL | ||
Patent #
US 20170020461A1
Filed 09/28/2016
|
Current Assignee
Welch Allyn Incorporated
|
Original Assignee
Welch Allyn Incorporated
|
Method and device for determining elapsed sensor life | ||
Patent #
US 9,574,914 B2
Filed 03/03/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing an emergency notification for an allergic reaction | ||
Patent #
US 9,589,443 B2
Filed 09/02/2014
|
Current Assignee
ATT Intellectual Property I LP
|
Original Assignee
ATT Intellectual Property I LP
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,610,034 B2
Filed 11/09/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 9,625,413 B2
Filed 05/19/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 9,649,057 B2
Filed 05/11/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing basal profile modification in analyte monitoring and management systems | ||
Patent #
US 9,669,162 B2
Filed 03/16/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Glucose measuring device for use in personal area network | ||
Patent #
US 9,730,584 B2
Filed 02/10/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for powering an electronic device | ||
Patent #
US 9,743,863 B2
Filed 06/01/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing notification function in analyte monitoring systems | ||
Patent #
US 9,750,439 B2
Filed 04/08/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing rolling data in communication systems | ||
Patent #
US 9,801,545 B2
Filed 07/30/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
SYSTEM AND METHOD FOR PROVIDING ALERTS OPTIMIZED FOR A USER | ||
Patent #
US 20170347971A1
Filed 08/23/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for providing an emergency notification for an allergic reaction | ||
Patent #
US 9,847,005 B2
Filed 03/06/2017
|
Current Assignee
ATT Intellectual Property I LP
|
Original Assignee
ATT Intellectual Property I LP
|
APPARATUS AND METHOD FOR ENHANCING PERSONAL INFORMATION DATA SECURITY | ||
Patent #
US 20180014198A1
Filed 01/19/2016
|
Current Assignee
Samsung Electronics Co. Ltd.
|
Original Assignee
Samsung Electronics Co. Ltd.
|
METHOD AND APPARATUS FOR MITIGATING BEHAVIOR ADVERSE TO A BIOLOGICAL CONDITION | ||
Patent #
US 20180035953A1
Filed 08/04/2016
|
Current Assignee
Welch Allyn Incorporated
|
Original Assignee
Welch Allyn Incorporated
|
Method and device for determining elapsed sensor life | ||
Patent #
US 9,949,678 B2
Filed 02/16/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 9,962,091 B2
Filed 01/06/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte signal processing device and methods | ||
Patent #
US 9,968,302 B2
Filed 04/04/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems | ||
Patent #
US 9,968,306 B2
Filed 10/21/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and method for providing alerts optimized for a user | ||
Patent #
US 9,974,903 B1
Filed 04/28/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods | ||
Patent #
US 9,980,669 B2
Filed 11/07/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated system for intravascular placement of a catheter | ||
Patent #
US 9,999,371 B2
Filed 10/31/2012
|
Current Assignee
C.R. Bard Inc.
|
Original Assignee
C.R. Bard Inc.
|
Method and system for providing data communication in continuous glucose monitoring and management system | ||
Patent #
US 10,039,881 B2
Filed 07/07/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Reconfirmation of ECG-assisted catheter tip placement | ||
Patent #
US 10,046,139 B2
Filed 11/19/2014
|
Current Assignee
C.R. Bard Inc.
|
Original Assignee
C.R. Bard Inc.
|
Method and apparatus for providing an emergency notification for an allergic reaction | ||
Patent #
US 10,055,962 B2
Filed 11/28/2017
|
Current Assignee
ATT Intellectual Property I LP
|
Original Assignee
ATT Intellectual Property I LP
|
System for placement of a catheter including a signal-generating stylet | ||
Patent #
US 10,105,121 B2
Filed 11/30/2016
|
Current Assignee
C.R. Bard Inc.
|
Original Assignee
C.R. Bard Inc.
|
Integrated systems for intravascular placement of a catheter | ||
Patent #
US 10,165,962 B2
Filed 05/08/2013
|
Current Assignee
C.R. Bard Inc.
|
Original Assignee
C.R. Bard Inc.
|
Analyte monitoring system and methods | ||
Patent #
US 10,178,954 B2
Filed 05/09/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,201,301 B2
Filed 04/18/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,231,654 B2
Filed 06/23/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Apparatus and method for catheter navigation and tip location | ||
Patent #
US 10,231,643 B2
Filed 09/04/2015
|
Current Assignee
BARD Access Systems Incorporated
|
Original Assignee
BARD Access Systems Incorporated
|
Insertion guidance system for needles and medical components | ||
Patent #
US 10,231,753 B2
Filed 11/30/2016
|
Current Assignee
C.R. Bard Inc.
|
Original Assignee
C.R. Bard Inc.
|
Apparatus for use with needle insertion guidance system | ||
Patent #
US 10,238,418 B2
Filed 06/30/2015
|
Current Assignee
C.R. Bard Inc.
|
Original Assignee
C.R. Bard Inc.
|
Apparatus and method for catheter navigation using endovascular energy mapping | ||
Patent #
US 10,271,762 B2
Filed 11/30/2016
|
Current Assignee
BARD Access Systems Incorporated
|
Original Assignee
BARD Access Systems Incorporated
|
System and method for providing alerts optimized for a user | ||
Patent #
US 10,328,204 B2
Filed 04/28/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Apparatus for use with needle insertion guidance system | ||
Patent #
US 10,342,575 B2
Filed 10/03/2016
|
Current Assignee
C.R. Bard Inc.
|
Original Assignee
C.R. Bard Inc.
|
Method and apparatus for providing notification function in analyte monitoring systems | ||
Patent #
US 10,349,874 B2
Filed 08/31/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Devices and methods for endovascular electrography | ||
Patent #
US 10,349,857 B2
Filed 09/15/2016
|
Current Assignee
BARD Access Systems Incorporated
|
Original Assignee
BARD Access Systems Incorporated
|
Connector interface for ECG-based catheter positioning system | ||
Patent #
US 10,349,890 B2
Filed 06/24/2016
|
Current Assignee
C.R. Bard Inc.
|
Original Assignee
C.R. Bard Inc.
|
System and method for non-intrusive health monitoring in the home | ||
Patent #
US 10,357,202 B2
Filed 11/03/2014
|
Current Assignee
Universal Electronics Inc.
|
Original Assignee
Universal Electronics Inc.
|
Method and apparatus for monitoring a functional capacity of an individual | ||
Patent #
US 10,368,810 B2
Filed 09/28/2016
|
Current Assignee
Welch Allyn Incorporated
|
Original Assignee
Welch Allyn Incorporated
|
Method and apparatus for providing an emergency notification for an allergic reaction | ||
Patent #
US 10,373,468 B2
Filed 08/20/2018
|
Current Assignee
ATT Intellectual Property I LP
|
Original Assignee
ATT Intellectual Property I LP
|
System and method for providing alerts optimized for a user | ||
Patent #
US 10,406,287 B2
Filed 07/06/2018
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring system and methods for managing power and noise | ||
Patent #
US 10,429,250 B2
Filed 03/26/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,478,108 B2
Filed 02/05/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method, apparatus and computer-readable medium for aiding emergency response | ||
Patent #
US 10,506,408 B2
Filed 04/27/2017
|
Current Assignee
Bryx Inc.
|
Original Assignee
Bryx Inc.
|
Tocodynamometer GPS alert system | ||
Patent #
US 10,595,792 B2
Filed 10/17/2017
|
Current Assignee
Fetal Life LLC
|
Original Assignee
Fetal Life LLC
|
Systems and methods for guiding a medical instrument | ||
Patent #
US 10,602,958 B2
Filed 11/30/2016
|
Current Assignee
C.R. Bard Inc.
|
Original Assignee
C.R. Bard Inc.
|
Method and apparatus for managing a biological condition | ||
Patent #
US 10,617,350 B2
Filed 09/14/2015
|
Current Assignee
Welch Allyn Incorporated
|
Original Assignee
Welch Allyn Incorporated
|
Method to provide ad hoc and password protected digital and voice networks | ||
Patent #
US 10,645,562 B2
Filed 06/07/2019
|
Current Assignee
AGIS Software Development LLC
|
Original Assignee
AGIS Software Development LLC
|
Analyte monitoring system and methods | ||
Patent #
US 10,653,317 B2
Filed 01/10/2019
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Devices used in connection with continuous analyte monitoring that provide the user with one or more notifications, and related methods | ||
Patent #
US 10,729,388 B2
Filed 10/27/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for providing alerts optimized for a user | ||
Patent #
US 10,737,025 B2
Filed 08/23/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 10,750,952 B2
Filed 03/26/2018
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Iconic representations for guidance of an indwelling medical device | ||
Patent #
US 10,751,509 B2
Filed 03/07/2014
|
Current Assignee
C.R. Bard Inc.
|
Original Assignee
C.R. Bard Inc.
|
Method and apparatus for mitigating behavior adverse to a biological condition | ||
Patent #
US 10,791,994 B2
Filed 08/04/2016
|
Current Assignee
Welch Allyn Incorporated
|
Original Assignee
Welch Allyn Incorporated
|
Interactive clinical diagnosis report system | ||
Patent #
US 10,803,579 B2
Filed 10/08/2018
|
Current Assignee
Beijing KEYA Medical Technology Company Limited
|
Original Assignee
Beijing KEYA Medical Technology Company Limited
|
System and method for generating and editing diagnosis reports based on medical images | ||
Patent #
US 10,803,581 B2
Filed 11/04/2018
|
Current Assignee
Beijing KEYA Medical Technology Company Limited
|
Original Assignee
Beijing KEYA Medical Technology Company Limited
|
Alarm notification system | ||
Patent #
US 10,825,568 B2
Filed 03/21/2018
|
Current Assignee
Masimo Corporation
|
Original Assignee
Masimo Corporation
|
Alarm notification system | ||
Patent #
US 10,832,818 B2
Filed 10/10/2014
|
Current Assignee
Masimo Corporation
|
Original Assignee
Masimo Corporation
|
Systems and methods for breaching a sterile field for intravascular placement of a catheter | ||
Patent #
US 10,849,695 B2
Filed 05/02/2017
|
Current Assignee
C.R. Bard Inc.
|
Original Assignee
C.R. Bard Inc.
|
Systems and methods for guidance and placement of an intravascular device | ||
Patent #
US 10,863,920 B2
Filed 12/08/2017
|
Current Assignee
C.R. Bard Inc.
|
Original Assignee
C.R. Bard Inc.
|
Device and system for locating and operating a medical device | ||
Patent #
US 10,874,796 B2
Filed 12/03/2014
|
Current Assignee
Micrel Medical Devices S.A.
|
Original Assignee
Micrel Medical Devices S.A.
|
System and method for monitoring and controlling the glycemic state of a patient | ||
Patent #
US 6,572,542 B1
Filed 03/03/2000
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Personal medical monitoring unit and system | ||
Patent #
US 6,579,231 B1
Filed 03/27/1998
|
Current Assignee
Apple Inc.
|
Original Assignee
MCI Communications Corporation
|
Method and apparatus for monitoring of cumulative-trauma-syndrome-inducing activities | ||
Patent #
US 6,402,708 B1
Filed 04/26/2001
|
Current Assignee
Agilent Technologies Incorporated
|
Original Assignee
Agilent Technologies Incorporated
|
Apparatus, method, and system for remote monitoring of need for assistance based on change in velocity | ||
Patent #
US 20020116080A1
Filed 02/16/2001
|
Current Assignee
Innovage LLC
|
Original Assignee
Locast Corporation
|
Buddy communicator | ||
Patent #
US 20020145522A1
Filed 04/05/2001
|
Current Assignee
Kevin Pembroke
|
Original Assignee
Kevin Pembroke
|
Patient care delivery system | ||
Patent #
US 6,302,844 B1
Filed 03/31/1999
|
Current Assignee
Inventor Holdings LLC
|
Original Assignee
Walker Digital LLC
|
Emergency command and control system | ||
Patent #
US 20010036832A1
Filed 04/12/2001
|
Current Assignee
Onscene Incorporated
|
Original Assignee
Onscene Incorporated
|
Vital sign remote monitoring device | ||
Patent #
US 5,919,141 A
Filed 09/13/1996
|
Current Assignee
LIFE SENSING INSTRUMENT COMPANY INC.
|
Original Assignee
LIFE SENSING INSTRUMENT COMPANY INC.
|
22 Claims
-
1. An emergency medical monitoring and transmission system capable of sending a message to both a personal caretaker and an emergency response center, said system comprising:
-
a wearable monitor/transmitter device that includes a glucose level detector to detect a blood glucose level of a patient, a geolocation system that indicates location of said patient, and a communication interface to send a message; a processor unit operable with said wearable monitor/transmitter device that collects information produced by said glucose level detector and said geolocation system to determine whereabouts and existence of a hypoglycemic or hyperglycemic condition of said patient, wherein said processor unit effects collection of blood glucose levels at time instances that vary according to proximity of a detected level to an unsafe limit;
said processor unit further including program instructions to effect assembly of said message that includes patient identifier data, whereabouts of said patient, and an emergency alert indication; and
said processor being further operable to effect activation of said communication interface to transmit said message in response to a hypoglycemic or hyperglycemic condition of said patient;a transmission path of said communication interface to send, in response to said emergency alert indication, an emergency message to an emergency response center and to said personal caretaker to simultaneously indicate at at least two locations that the patient requires assistance; and a caretaker receiver accessible by a personal caretaker of said patient to receive said message and to produce an alarm indicating that the patient requires assistance in response to receipt of said emergency alert indication. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A portable medical monitoring and transmission system that sends an emergency message to call for assistance, said system comprising:
-
a portable monitor/transmitter device including a glucose level detector to detect a blood glucose level of a patient, a patient position monitor that indicates location of said patient, a reservoir of glucose and a pump to administer said glucose to the patient, and a transmitter to send said emergency message; a reset switch operative to inhibit said transmitter and to forego administration of said glucose to the patient; a processor operable with said portable monitor/transmitter device to effect acquisition of information produced by said glucose level detector and said patient position monitor to determine whereabouts and existence of an unsafe medical condition of said patient, said processor further including program instructions to effect assembly of said emergency message to include patient identifier data, patient position information, and an emergency alert indication to issue a prompt to said patient to self-treat said unsafe condition and, in response to a failure of said patient to acknowledge said prompt within a given time period, to effect activation of said transmitter to transmit said emergency message and activation of said glucose pump to automatically administer glucose to said patient, and in response to an acknowledgement of the prompt by the patient within said given time period, to effect operation of said reset switch to inhibit said transmitter and forego administration of glucose by said glucose pump; and a transmission path of said transmitter to send, in response to said emergency alert indication, said emergency message to an emergency response center indicating that the patient requires assistance. - View Dependent Claims (11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)
-
-
22. A method of sending an alert that a diabetic patient needs assistance utilizing a system provided with a reset switch to inhibit sending said alert, said method comprising the steps of:
-
detecting a blood glucose level of said patient to produce blood glucose level information, determining the location of said patient, accessing said blood glucose level information and determining whether said information lies within preset limits corresponding to a hypoglycemic or hyperglycemic condition of said patient, in response to said information lying outside said preset limits, prompting the patient to self-treat an unsafe condition, upon a failure of the patient to acknowledge said prompting within a given time period, (i) automatically treating said patient with an injection of glucose from a wearable reservoir of glucose, (ii) assembling an emergency message that identifies said patient, whereabouts of said patient, and an emergency alert indication; and (iii) transmitting said emergency message to one of an emergency response center and a personal caretaker to indicate that the patient requires assistance, and in response to the patient acknowledging said prompting within a given time period, activating said reset switch to forego said treating and transmitting steps.
-
1 Specification
This invention claims the benefit of U.S. patent application Ser. No. 10/736,105 filed Dec. 11, 2003 entitled Glucose Locator Transmitter.
This invention relates to an emergency medical monitoring and response system and method, but more specifically, to a wearable device and related support personnel communication equipment to detect an emergency medical condition of diabetic patient and/or to report such condition to a personal caretaker.
Diabetes afflicts a significant portion of the population. The disease affects persons whose bodily functions are unable to maintain a proper blood glucose level without medication, diet or treatment. An insulin injection is common treatment when glucose levels rise when bodily functions fail to produce sufficient insulin while sugar consumption treats low blood glucose levels. If an unsafe blood glucose condition remains untreated—even for a few moments—the patient may lose consciousness, become comatose, suffer irreparable brain damage, and possibly die. As such, persons suffering from diabetes must constantly be monitored and guarded against hypoglycemia or hypoglycemia, which restricts the person'"'"'s activity and mobility.
Thus, a goal of the present invention is to enable substantially unrestricted mobility of diabetic individual without an undue risk of a lapse in treatment should an emergency condition arise.
It is another goal of the present invention to provide a wearable device that automatically monitors blood glucose levels and to prompt the patient to take appropriate action and, when the patient is unable to perform self-treatment, to transmit an emergency message as to the patient'"'"'s condition and whereabouts to a personal caretaker and/or emergency medical response center, such as a hospital or an ambulatory service.
It is another goal of the present invention to provide a wearable device, as aforestated, that includes a location detector such as a GPS receiver, and a transceiver, such as a cellular telephone interface, to provide a transmission of the patient'"'"'s condition, whereabouts, or other information.
It is another goal of the present invention to provide a wearable device that automatically treats a diabetic upon detection of an unsafe blood glucose level should the diabetic fails to implement self-treatment within a predetermined period of time after detection of an unsafe diabetic condition.
According to a first aspect of the invention, there is provided an emergency medical monitoring and transmission system capable of sending a message to a personal caretaker and/or an emergency response center where the system comprises a wearable monitor/transmitter device including a glucose detector to detect a blood glucose level of a patient, a geolocation system that indicates the patient'"'"'s location, and a communication interface to send and/or receive an emergency message; and a processor operable with the wearable monitor/transmitter device to collect information produced by the glucose detector and the geolocation system to determine the whereabouts and/or existence of a hypoglycemic or hyperglycemic condition of the patient. The processor further includes program instructions to effect assembly of a message that includes patient identifier data, whereabouts information, and an emergency alert indication. The processor activates the communication interface to transmit the message in response to a hypoglycemic or hyperglycemic condition of the patient. The system optionally includes a caretaker receiver accessible by a personal caretaker of the patient to receive the message and, in response to receipt of said emergency alert indication, to produce an alarm indicating that the patient requires assistance. Further, the system includes a transmission path to send, in response to an emergency alert indication, an emergency message to an emergency response center indicating that the patient requires assistance.
An additional feature of the invention includes the emergency message having patient identifier and whereabouts data embedded therein, and a receiver located at an emergency medical response center to receive the emergency message, to produce an alarm, and to display the patient'"'"'s condition and whereabouts.
An additional feature of the invention includes the processor having program instructions to produce and record historical trend information indicating past levels of blood glucose.
An additional feature of the invention includes the processor effecting transmission of blood glucose level historical trend information to at least one of the caretaker receiver and the emergency response center.
An additional feature of the invention includes the processor effecting collection of blood glucose levels at time instances that vary according to proximity of a detected level to an unsafe upper or lower limit.
An additional feature of the invention includes a wireless network interface of the system to communicate with a wireless network access point of a facility of the patient, where the message is relayed to the personal caretaker and/or the emergency response center.
An additional feature of the invention includes a panic switch on the unit worn by the patient where a processor thereof responds to activation of the panic switch to effect immediate transmission of an emergency message.
An additional feature of the invention includes a reset switch on the unit worn by the patient where the processor responds to activation of the reset switch to cancel an alarm condition and/or to inhibit transmission of the emergency message.
An additional feature includes an glucose reservoir and glucose pump disposed on the unit worn by the patient where the processor effects automatic administration of glucose from the reservoir through a catheter and into the patient upon a failure of the patient to acknowledge an alarm condition within a predetermined time period, e.g., three to five minutes, more or less. The processor may control the amount of glucose injection to be commensurate with the extent of a sensed hypoglycemic condition, as measured by the glucose level detector.
According to another aspect of the invention, there is provided a portable medical monitoring and transmission system that sends an emergency message to an emergency response center comprising a portable monitor/transmitter device including a glucose level detector to detect a blood glucose level of a patient, a patient position monitor that indicates the location of the patient, and a transmitter to send the emergency message; a processor operable with the portable monitor/transmitter device worn by the patient to effect acquisition of data produced by the glucose level detector and the patient position monitor to determine whereabouts and existence of an unsafe medical condition of the patient, the processor further including program instructions to effect assembly of the emergency message to include patient identifier data, patient position information, and/or an emergency alert indication, and to activate the transmitter to transmit the emergency message in response to the unsafe medical condition; and a transmission path of the transmitter to send, in response to an emergency alert indication, the emergency message to an emergency response center and/or a personal caretaker indicating that the patient requires assistance.
According to another aspect of the invention, a method of sending an alert that a diabetic patient needs assistance comprises the steps of detecting a blood glucose level of the patient to produce blood glucose level information; determining the location of the patient, accessing the blood glucose level information to determine whether the information lies within preset limits corresponding to a hypoglycemic or hyperglycemic condition of the patient; in response to the information lying outside of he preset limits, assembling an emergency message that identifies the patient, the whereabouts of the patient, and an emergency alert indication; and transmitting the emergency message to an emergency response center and/or a personal caretaker of the patient to indicate that the patient requires assistance. The method may additionally comprise inhibiting the transmitting step in response to a cancel alarm signal produced by the patient. Further, the method may additionally comprise automatically injecting glucose into the patient upon a failure to acknowledge the emergency alert indication within a given time period after the glucose monitor detects a hypoglycemic condition, e.g., low blood glucose level.
Other aspects and features of the invention will become apparent upon review of the following detailed description of illustrative embodiments taken in connection with the accompanying drawings. The invention, though, is pointed out with particularity by the appended claims.
Wearable transceiver device 10 preferably includes a glucose monitor, such as a GlucoWatch G2 Biographer commercially available from Cygnus, Inc. of Redwood City, Calif., a GPS (global positioning system) module to detect the location of patient 12, and a communication interface and transceiver device such as mobile telephone and interface. Such a GPS module is commercially available from Motorola or Analog Devices (e.g., NAV 2300 navigation chip). The glucose level detector collects and analyzes glucose through the patient'"'"'s skin, typically at the wrist. Wearable device 10 also includes a special purpose processor interfaced with the GPS module, the glucose level monitor, and a communication interface to effect transmission of an emergency message to the personal caretaker 10 or emergency personnel 22 that identifies the patient, his or her whereabouts, an emergency medical condition, and/or other pertinent information about the patient. Other attributes of wearable device 10 include a display that displays glucose levels, an audible and/or visual local alarm to alert the patient of the onset and/or existence of an unsafe medical condition, a “panic switch” enabling the patient to immediately call for help, and a reset switch to reset the device 10 or cancel an alarm (locally and remote transmission thereof) at the will of the patient. The local alarm may also include a vibrator or buzzer to warn the patient of an unsafe medical condition.
The personal caretaker'"'"'s receiver device 14 receives messages from the patient'"'"'s wearable device 10 via network 18. Such messages may include patient identifying information, blood glucose levels, an the patient'"'"'s whereabouts. Device 14 may also include a transmitter or cellular telephone interface to send messages either to patient 12 or emergency response personnel 22. Device 20 preferably comprises installed communication equipment located at the emergency response center.
In practice, data terminals that drive the display of a conventional, off-the-shelf GPS chip may supply the contents of location register 26. Information of date/time clock 28 may also be derived from GPS timing signals. ID register 36 may comprise a unique serial number associated with the patient, or personalized data such as the patient name, medical history, address, emergency contact information, or any other information pertinent to treatment or identity of the patient.
Input 38 may comprise a simple contact switch or a numeric of alphanumeric keypad for entering information into elements of device 10, such as personal patient data; location information; device 10 control information, e.g., reset, cancel emergency, or delay emergency; or any other information. In the case where input 38 comprises a contact switch, processor 30 may serially prompt inputs from the patient in conjunction with voice or text prompts on display 46 in order to enter information into device 10.
Bus 34, which also communicates with processor 30, includes a glucose sensor 40; a panic switch 42 to enable the patient 12 to immediately call for help via an emergency message; a memory 44 that stores information and program instructions associated with processor 30; a display to provide textual information, such as glucose levels, to the patient; an alarm 48 to provide a visual and/or audible alarm to the patient, and optionally, a vibratory alarm 49, which also notifies the patient of an emergency medical condition. Panic switch 42 may comprise a contact switch, closure of which is detected by processor 30 via an interrupt line of the processor. Panic switch 42 may also comprise a voice-activated switch, a speech analyzer to receive and respond to verbal commands, or any other input that can be interpreted by processor 30.
In an exemplary operation, processor 30 effects periodic sampling and/or collecting of glucose levels measured by sensor 40 and compares the same with pre-stored limits to determine whether monitored levels lie within a safe range. A indicated above, glucose detector 40 may comprise an off-the-shelf sensor having data ports feeding a local display. Taps can be made on these data ports to collect glucose measurement data, which is acquired by processor 30. Collected information is time/date stamped using time data produced by local clock source 28 and stored in memory 44.
If processor 30 detects an out-of-limit glucose level, it activates a local alarm giving warning to the patient to implement corrective action. Notification may occur using local alarm 48 or 49. The patient may turn off the local alarm or delay transmission of an emergency message at will, via an input 38. If, after processor 30 detects an unsafe medical condition and the patient fails to reset the device 10 or delay emergency message transmission within a specified time, e.g., thirty to sixty seconds, processor 30 assembles an emergency message and activates transceiver 39 to send the message to either or both the personal caretaker 16 (
In addition, transceiver 39 may be configured to co-act with a local communication system located at the premises of the patient, such as an existing telephone, a personal computer having Internet access, or wireless access points of a wireless network. In this case, transceiver 39 communicates with the local communication system, which, in turn, relays the message to the personal caretaker or the emergency response center via a network or direct communication link.
Display 46, e.g., a backlighted liquid crystal display panel, provides a visual indication of glucose levels enabling the patient to determine whether to perform self-treatment or whether outside medical assistance is necessary. Moreover, although
In special a case where secure access is required to the patient'"'"'s home or other facility, control facility 74 of the emergency response unit 20 is operable to implement secure access such as by entering access codes or unlocking an access door 76 of the patient'"'"'s home 78, as shown in
Assuming device 10 reaches a normal operating or “green light” state and no system errors are encountered during initialization, step 81 effects acquisition of glucose levels from sensor 40 via buss 34 and stores that information in memory 44. At step 82, processor 30 checks or tests whether the patient has activated the panic switch 42 (
If, at step 82, processor 30 does not sense activation of panic switch 42, the algorithm proceeds to step 83 to test whether the sensed glucose level lies within proper high and low limits, which may be programmed to correspond to specific hyperglycemia and hypoglycemia conditions of the patient. Such limits may be custom-programmed or predetermined individually for each patient since an alarm condition may differ among diabetic individuals. If, at step 83, a currently detected glucose level lies within the predetermined and proper range, the algorithms loops back to step 81 where a new glucose level is obtained from glucose sensor 40. The periodicity of looping or looping interval may, for example, be set between five and fifteen minutes, more or less, depending on the extent of the patient'"'"'s monitoring needs and/or the cycle time of glucose sensor 40. In urgent cases, monitoring may occur every minute but in mild case, monitoring may occur every half-hour, hour, or even longer. The periodicity or intervals between monitoring may also be controlled according to historical trend information and/or the proximity of a measured glucose level to an unsafe limit. For example, if processor 30 detects a persistent rise in glucose levels towards a hyperglycemic limit or a persistent decrease in blood glucose level towards a hypoglycemic limit, intervals between measurements or sampling may be shortened, e.g., every minute to every five minutes, more or less. Contrary, if a detected glucose level approaches a mid-point or safe range, measurement intervals may be lengthened.
When, at step 83, processor 30 determines that the currently sensed glucose level lies outside a safe limit or is approaching an unsafe preset limit, step 84 effects activation of local alarm 48 and/or 49 (
Algorithms implemented by the processor 50 (
Processor 50 (
At the emergency response center, processor 64 (
A further embodiment of the invention includes an automatic glucose injection system responsive to a failure of the patient to respond by administering self-treatment when the glucose level detector detects a low blood glucose level. This is especially advantageous for critically afflicted diabetics or where a caretaker or emergency response personnel cannot or will not likely reach the patient before criminality (e.g., patient becoming comatose), which may occur within fifteen to twenty minutes, more or less, in certain cases.
The invention is not limited by the illustrative method and apparatus embodiments described above, it being understood that persons having skill in the art may envision further modifications, substitutions, and alterations to the illustrated embodiments without departing from the invention, as defined by the appended claims.